The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
Afon Technology, founded by Dr Sabih Chaudhry in 2019, has been a leader in diabetes innovation with its Glucowear™ device, the world’s first non-invasive glucose sensor that continuously monitors blood sugar levels in real-time.
Laura Kirschbacher, Corporate Communications Manager at Pfalzklinikum AdöR talks about ward-equivalent treatment (WeT), a special kind of hometreatment, where a multi-professional team visits the patients at home: She accompanied WeT social worker Linda Seez to find out more.
As research finds more than half (58%) of allergy sufferers have had their lives put at risk by restaurant or takeaway staff, law firm Slater and Gordon are calling on businesses to have better allergen control.
The new, free training is aimed at organisations of less than 250 people to promote wellbeing in the workplace and is available online at the Mental Health at Work website.
Jérôme Galon, Director of Research and Head of the Laboratory of Integrative Cancer Immunology at INSERM, explains Immunoscore®, an in vitro diagnostic test that predicts the risk of relapse in colon cancer patients.
Brendan Crossey, Chief Executive Officer of Healthcare Analytics Limited places the adoption of effective medical bed tracking under the spotlight, including the innovative use of technology in this aspect of healthcare.
THz and millimetre wave frequency techniques, combined with thin film measurement methods, provide early detection of corneal edema associated with disease in the view of Zachary Taylor, Assistant Professor at Aalto University.
Jane Kinghorn, Director of the Translational Research Office at UCL, discusses the importance of research and partnership in improving the health and wealth of the UK.
Goran Nenadic, from The University of Manchester and The Alan Turing Institute, argues for using patient information stored in routinely collected healthcare free-text data.
Taking advantage of data and trustworthy collaboration is the way to go when it comes to a life- and disease course approach to health protection and chronic care, argues Prof Dr Freimut Schliess, Director of Science & Innovation at Profil GmbH.
Takeshi Iwata, Division Director at the National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, tells us about advancing research and developing new therapies for inherited retinal eye diseases.
DiaChemo is a European project developing a platform technology for point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond, reveals Dr Silke Krol, Head of the Translational Nanotechnology Lab and Coordinator of the DIACHEMO Project.
